Cargando…
SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
Meningiomas represent the most frequently diagnosed intracranial tumors. Inflammation and immune processes may play an important role in therapeutic response as well as in anti- and pro-tumor modulating function. In tumors, inflammatory markers have been able to provide useful prognostic information...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208882/ http://dx.doi.org/10.1210/jendso/bvaa046.553 |
_version_ | 1783530950136692736 |
---|---|
author | Leães Rech, Carolina Garcia Soares Minuzzi, Ricardo Kunde Silva, Camila Batista de Oliveira Araújo, Bruna Mafalda, Tainá Ferreira, Nelson Pires Oliveira, Miriam da Costa Pereira-Lima, Júlia F Semmelmann |
author_facet | Leães Rech, Carolina Garcia Soares Minuzzi, Ricardo Kunde Silva, Camila Batista de Oliveira Araújo, Bruna Mafalda, Tainá Ferreira, Nelson Pires Oliveira, Miriam da Costa Pereira-Lima, Júlia F Semmelmann |
author_sort | Leães Rech, Carolina Garcia Soares |
collection | PubMed |
description | Meningiomas represent the most frequently diagnosed intracranial tumors. Inflammation and immune processes may play an important role in therapeutic response as well as in anti- and pro-tumor modulating function. In tumors, inflammatory markers have been able to provide useful prognostic information for treatment or clinical evaluation of patients. The aim of this study was to investigate preoperative hematological markers concerning recurrence or regrowth and clinical variables in meningioma. Eighty nine patients with no corticosteroid therapy were included. Blood tests and tumor characteristics were collected from medical records. Recurrence-free survival was evaluated using Cox regression and Kaplan-Meier curves. Of the 89 cases, 73 (82%) were grade I and 16 (18%) grade II. The mean age was 53±13.9 years, with higher frequency in women, 2:1 proportion. The most frequent subtypes were meningothelial (40.4%), transitional (23.5%) and atypical (17.9%), 64% with peripheral location and 64% had a size greater than 3 cm. Regarding tumor resection, 49 (55.1%) underwent complete surgery (40 remained with tumor (81.6%) and 9 relapse (18.3%)) and 40 (44.9%) submitted to partial resection surgery (29 remained with persistent lesion (72.5%) and 11 regrowth (25%)). In total, 20 (22.4%) cases of recurrence or regrowth were observed. The median recurrence-regrowth free survival (RFS) was 62 months, 96.1% at 1 year, 67.4% at 3 years and 51.2% at 5 years. In univariate analysis, anemia (p=0.04), neutrophilia (p=0.02) and neutrophilis/lymphocyts ratio (NLR) (p=0.03) were associated with an increased risk of recurrence or regrowth and poor RFS. In multivariate, the interaction between anemia and NLR >4 represented a higher risk of recurrence or regrowth (p=0.003). The preoperative presence of anemia, neutrophilia, and NLR was associated with an increased risk of recurrence or regrowth in meningiomas, emphasizing the importance of preoperative evaluation of these parameters. |
format | Online Article Text |
id | pubmed-7208882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72088822020-05-13 SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas Leães Rech, Carolina Garcia Soares Minuzzi, Ricardo Kunde Silva, Camila Batista de Oliveira Araújo, Bruna Mafalda, Tainá Ferreira, Nelson Pires Oliveira, Miriam da Costa Pereira-Lima, Júlia F Semmelmann J Endocr Soc Tumor Biology Meningiomas represent the most frequently diagnosed intracranial tumors. Inflammation and immune processes may play an important role in therapeutic response as well as in anti- and pro-tumor modulating function. In tumors, inflammatory markers have been able to provide useful prognostic information for treatment or clinical evaluation of patients. The aim of this study was to investigate preoperative hematological markers concerning recurrence or regrowth and clinical variables in meningioma. Eighty nine patients with no corticosteroid therapy were included. Blood tests and tumor characteristics were collected from medical records. Recurrence-free survival was evaluated using Cox regression and Kaplan-Meier curves. Of the 89 cases, 73 (82%) were grade I and 16 (18%) grade II. The mean age was 53±13.9 years, with higher frequency in women, 2:1 proportion. The most frequent subtypes were meningothelial (40.4%), transitional (23.5%) and atypical (17.9%), 64% with peripheral location and 64% had a size greater than 3 cm. Regarding tumor resection, 49 (55.1%) underwent complete surgery (40 remained with tumor (81.6%) and 9 relapse (18.3%)) and 40 (44.9%) submitted to partial resection surgery (29 remained with persistent lesion (72.5%) and 11 regrowth (25%)). In total, 20 (22.4%) cases of recurrence or regrowth were observed. The median recurrence-regrowth free survival (RFS) was 62 months, 96.1% at 1 year, 67.4% at 3 years and 51.2% at 5 years. In univariate analysis, anemia (p=0.04), neutrophilia (p=0.02) and neutrophilis/lymphocyts ratio (NLR) (p=0.03) were associated with an increased risk of recurrence or regrowth and poor RFS. In multivariate, the interaction between anemia and NLR >4 represented a higher risk of recurrence or regrowth (p=0.003). The preoperative presence of anemia, neutrophilia, and NLR was associated with an increased risk of recurrence or regrowth in meningiomas, emphasizing the importance of preoperative evaluation of these parameters. Oxford University Press 2020-05-08 /pmc/articles/PMC7208882/ http://dx.doi.org/10.1210/jendso/bvaa046.553 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Tumor Biology Leães Rech, Carolina Garcia Soares Minuzzi, Ricardo Kunde Silva, Camila Batista de Oliveira Araújo, Bruna Mafalda, Tainá Ferreira, Nelson Pires Oliveira, Miriam da Costa Pereira-Lima, Júlia F Semmelmann SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas |
title | SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas |
title_full | SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas |
title_fullStr | SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas |
title_full_unstemmed | SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas |
title_short | SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas |
title_sort | sun-130 preoperative hematological parameters associated with recurrence or regrowth of meningiomas |
topic | Tumor Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208882/ http://dx.doi.org/10.1210/jendso/bvaa046.553 |
work_keys_str_mv | AT leaesrechcarolinagarciasoares sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT minuzziricardokunde sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT silvacamilabatistadeoliveira sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT araujobruna sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT mafaldataina sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT ferreiranelsonpires sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT oliveiramiriamdacosta sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas AT pereiralimajuliafsemmelmann sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas |